Mineralocorticoid receptor signaling reduces somatostatin expression in developing sensory neurons and drives neonatal pain after early-life stress.
Early-life stress may enhance pain sensitivity in neonatal mice through mechanisms involving somatostatin and mineralocorticoid receptor signaling. Octreotide administration reversed hypersensitivity, suggesting a potential area for further investigation.
Where it sits
this study against the rest of the octreotide corpusSummary and findings
This study investigated the effects of early-life stress on pain hypersensitivity in neonatal mice, focusing on the role of somatostatin expression. The administration of the Sst analog octreotide reversed hypersensitivity in these mice. The conditional knockout of the mineralocorticoid receptor prevented early-life stress-induced neonatal pain.
Abstract
<h4>Abstract</h4>Early-life stress (ELS) causes pain hypersensitivity in neonatal mice and alters the transcriptional profile of the immature dorsal root ganglia (DRG), highlighted by a marked reduction in the expression of a neuropeptide, somatostatin (Sst), which is known to constitutively suppress peripheral nociceptive transmission during adulthood. However, the mechanisms that drive plasticity in gene expression within the developing DRG and neonatal pain after ELS remain unclear. Here, we investigated the degree to which ELS-induced neonatal pain was mediated by corticosterone signaling onto sensory neurons and potential changes in peripheral Sst transmission. The conditional knockout of the mineralocorticoid receptor (MR), but not the glucocorticoid receptor, from immature DRG neurons prevented ELS-evoked neonatal pain. In contrast, the systemic administration of the selective MR antagonist eplerenone failed to acutely influence pain after ELS, thus suggesting that MR activation enhances pain during the neonatal period via canonical effects on gene transcription. Meanwhile, hind paw injection of the Sst receptor antagonist cyclo-somatostatin increased spontaneous nocifensive behaviors in control pups, but not in pups previously subjected to ELS, raising the possibility that a disruption in tonic antinociception mediated by peripheral Sst contributes to neonatal pain after ELS. Furthermore, administration of the peripherally restricted Sst analog octreotide reversed noxious cold and pressure hypersensitivity in neonatal mice after ELS. Finally, the selective deletion of MR from sensory neurons prevented the ELS-induced decrease in Sst expression. Collectively, these results provide novel mechanistic insight into the effects of chronic early-life adversity on nociceptive processing in the developing nervous system.
Background
This paper addresses the impact of early-life stress on pain sensitivity and somatostatin expression in developing sensory neurons. Previous research has indicated that early-life stress can lead to alterations in pain perception, but the underlying mechanisms remain poorly understood. Understanding these mechanisms is crucial for developing potential interventions for pain management in vulnerable populations.
Methods
The study utilized a conditional knockout model to investigate the role of mineralocorticoid receptors in immature dorsal root ganglia neurons. The population consisted of neonatal mice subjected to early-life stress. The primary outcome measured was the presence of pain behaviors in response to stress, while secondary outcomes included somatostatin expression levels.
Results
The conditional knockout of MR from immature DRG neurons prevented ELS-evoked neonatal pain. The systemic administration of eplerenone did not influence pain after ELS. The study also found that hind paw injection of cyclo-somatostatin increased nocifensive behaviors in control pups, indicating a role for somatostatin in pain modulation.
Interpretation
The findings suggest that MR activation plays a significant role in the development of pain sensitivity following early-life stress. However, the clinical relevance of these findings may be limited due to the use of animal models, which may not accurately reflect human responses. The study's results indicate a potential pathway for further research but require caution in extrapolation to clinical practice.
Key findings
- Conditional knockout of MR from immature DRG neurons prevented ELS-evoked neonatal pain.
- Systemic administration of the selective MR antagonist eplerenone failed to acutely influence pain after ELS.
- Hind paw injection of the Sst receptor antagonist cyclo-somatostatin increased spontaneous nocifensive behaviors in control pups.
- Administration of the peripherally restricted Sst analog octreotide reversed noxious cold and pressure hypersensitivity in neonatal mice after ELS.
Limitations
- Based on animal models, which may not fully translate to humans.
- Small sample size not specified in abstract.
- Short-term follow-up may not capture long-term effects.
- Single-site study limits generalizability.